Literature DB >> 18648734

Gatifloxacin-induced severe hyperglycaemia and ketoacidosis in a non-diabetic renal transplant recipient.

Ambar Khaira1, Ankur Gupta, Nikhil Tandon, Sanjay K Agarwal.   

Abstract

Gatifloxacin has been reported to cause dysglycaemia, especially in the elderly and in diabetics. In this communication, we describe a case of a non-diabetic renal transplant recipient who came to us in a state of diabetic ketoacidosis following the use of gatifloxacin for a urinary tract infection.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18648734     DOI： 10.1007/s10157-008-0072-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


  10 in total

1.  Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients.

Authors:  Wendy S Biggs
Journal:  J Am Board Fam Pract       Date:  2003 Sep-Oct

2.  People with diabetes should avoid antibiotic gatifloxacin.

Authors:  Claire Kendall; Eric Wooltorton
Journal:  CMAJ       Date:  2006-03-22       Impact factor: 8.262

Review 3.  Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature.

Authors:  Clifford Yip; Audrey J Lee
Journal:  Clin Ther       Date:  2006-11       Impact factor: 3.393

4.  Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats.

Authors:  Yasuyoshi Ishiwata; Yasuaki Sanada; Masato Yasuhara
Journal:  Biol Pharm Bull       Date:  2006-03       Impact factor: 2.233

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 6.  Clinical pharmacology of gatifloxacin, a new fluoroquinolone.

Authors:  D M Grasela
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

7.  Severe hyperglycemia during renally adjusted gatifloxacin therapy.

Authors:  Amy L Blommel; Ronald A Lutes
Journal:  Ann Pharmacother       Date:  2005-06-07       Impact factor: 3.154

8.  Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.

Authors:  Atsunori Saraya; Masaaki Yokokura; Tohru Gonoi; Susumu Seino
Journal:  Eur J Pharmacol       Date:  2004-08-16       Impact factor: 4.432

9.  Outpatient gatifloxacin therapy and dysglycemia in older adults.

Authors:  Laura Y Park-Wyllie; David N Juurlink; Alexander Kopp; Baiju R Shah; Therese A Stukel; Carmine Stumpo; Linda Dresser; Donald E Low; Muhammad M Mamdani
Journal:  N Engl J Med       Date:  2006-03-01       Impact factor: 91.245

10.  Advancing age and renal impairment as important predisposing factors of gatifloxacin-induced hyperglycemia in non-diabetes patients.

Authors:  Mudjalin Ovartlarnporn; Wallaya Jongjaroenprasert
Journal:  J Med Assoc Thai       Date:  2007-03
  10 in total
  1 in total

1.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.